to taurine. The enzyme shows no conjugating activity with glycine, showing that it is a specific taurine conjugator. Acnat1 is mainly expressed in liver and kidney and the gene is localized in a gene cluster, together with two further acyltransferases, one of which conjugates bile acids to glycine and taurine. In conclusion, these data describe ACNAT1 as a new acyltransferase, involved in taurine conjugation of fatty acids in peroxisomes, identifying a novel pathway for production of N-acyltaurines as signaling molecules or for excretion of fatty acids.
INTRODUCTION
The conjugation of xenobiotics to amino acids is one of the first described drug metabolizing reactions known and dates back to 1842 (1) . It is now well established that a wide variety of endogenous carboxylic acids and xenobiotics are conjugated with amino acids in reactions catalyzed by different acyltransferase enzymes (2) .
These include both endogenous compounds like bile acids, fatty acids, and various drugs containing carboxyl groups such as clofibric acid and lovastatin (3) (4) (5) (6) (7) . Amino acid conjugation occurs in a two-step process. The first step involves activation of the carboxylic acid to the CoA ester which is catalyzed by acyl-CoA synthetases (8) . The second step, the conjugation reaction, is catalyzed by an acyl-CoA:amino acid Nacyltransferase (EC 2.3.1). While the conjugation of carboxylic acids and bile acids with taurine and glycine is the most common, L-asparagine and L-glutamine have also been shown to act as weak acceptors (9) . The conjugation of carboxylic acids to amino acids is important as it increases the solubility of these compounds, allowing them to be excreted in urine or bile, and acts as a detoxification system for excretion of xenobiotics. The conjugation of xenobiotics is mainly linked to mitochondria and glycine conjugating enzymes have been identified in this organelle in several species (9) (10) (11) (12) . In some cases however, the metabolism of xenobiotic acyl compounds also occurs in peroxisomes (13) .
Peroxisomes are organelles that are present in virtually all eukaryotic cells and are involved in the metabolism of a variety of lipids such as very long chain fatty acids, dicarboxylic acids, prostaglandins, leukotrienes, branched-chain fatty acids, xenobiotics and bile acids (14) . In peroxisomes, many of these lipids are mainly oxidized by the peroxisomal β-oxidation system, where they are chain-shortened, with the concomitant release of acetyl-CoA. In the case of primary bile acid synthesis, trihydroxycholestanoic acid and dihydroxycholestanoic acid are activated to their corresponding CoA esters by very long chain acyl-CoA synthetase (VLCS) (15) and then undergo one cycle of β-oxidation in peroxisomes, to produce choloyl-CoA and chenodeoxycholoyl-CoA respectively (16) BACAT has been characterized from several species and shows large species differences in the use of glycine or taurine as an acceptor molecule (3) (4) (5) 17) .
BACAT is related to a family of proteins called the Type-I acyl-CoA thioesterases (ACOTs) (for review see (18) ). These ACOT enzymes show approximately 40-45% sequence identity at amino acid level to the BACAT enzyme (3, 4) . Acyl-CoA thioesterase enzymes catalyze the hydrolysis of CoA esters of fatty acids to the free fatty acid and coenzyme A (CoA), whereas BACAT conjugates bile acids and fatty acids to glycine and taurine, using the bile acid-CoA or acyl-CoA moiety as a substrate. Using Blast Searches, we have now identified a novel peroxisomal enzyme in mouse that we name acyl-CoA:amino acid N-acyltransferase 1 (ACNAT1), which is related to both BACAT and the Type-I ACOTs. In this study, we have characterized this novel peroxisomal acyltransferase and show that it efficiently conjugates long-chain fatty acids to taurine. Purification of recombinant ACNAT1 -Bacteria were sonicated in pulses of 12 x 5 sec at 5 sec intervals and centrifuged at 9,000 x g at 4˚C for 30 min. The supernatant was filtered through a 0.22 µm filter and recombinant protein purified using amylose resin (New England Biolabs Inc. Beverly, MA, USA). The recombinant protein was eluted with column buffer containing 10 mM maltose. 37˚C after which the samples were purified using Sepac C18 columns (International Sorbent Technologies, UK) essentially as described in (5), but the column was washed with 3 ml water and samples eluted with 3 ml methanol A standard of nonadecanoic acid was added to the incubation mixtures prior to column purification.
MATERIALS AND METHODS

Chemicals-
Electrospray mass spectrometry (ES-MS) analysis-
The eluate was dried under nitrogen and samples reconstituted in ~100 µl methanol.
The samples were injected into a Quattro Micro triple quadrupole mass spectrometer (Micromass, Manchester, UK) at a flow rate of 10 µl/min. Mass spectra were acquired in the negative ion mode over a mass scan range of m/z 100-1000 for 2 min at a scan rate of 4 sec per scan.
Localization of ACNAT1 in peroxisomes using green fluorescent fusion protein and cell transfections-Oligonucleotides were designed based on the sequence of the ORF for Acnat1 for cloning as a fusion protein in-frame with green fluorescent protein (GFP). The ORF of Acnat1 was amplified by RT-PCR from mouse kidney total RNA using the following primers: 5'-CATATGATGATCCAGTTGATAGCC-3' and 5'-CATATGTACTCTGGCATGGACACTCT-3'. PCR was performed in a PerkinElmer 2600 using the One Step RNA PCR kit (AMV) (Takara Biomedical, Shiga, Japan) and the PCR product was cloned into the pcDNA3.1/NT-GFP vector (Invitrogen), in-frame with GFP. Sequence analysis was performed using Big Dye
Terminator Ready Reaction kit (Applied Biosystems Inc, CA, USA). Human skin fibroblasts from a control subject and a Zellweger patient were grown as described previously (19) . The cells were grown overnight in 60-mm dishes on glass coverslips and were transfected with 10 µg of ACNAT1/NT-GFP plasmid using the calcium phosphate method. The cells were fixed and processed for immunofluorescence microscopy as described in (19) . 
RESULTS
Identification of Acnat1 -We previously identified and cloned a novel gene family of
ACOTs in mouse, with members identified in cytosol (Acot1), mitochondria (Acot2) and peroxisomes (Acot3, Acot4, Acot5, Acot6) (20) (21) (22) (23) . When these genes were identified, they showed homology only to Bacat, an enzyme involved in the conjugation of bile acids. Following the advent of genome sequencing and using EST database searches, we have now identified two further genes which were mapped to mouse chromosome 4 B3, and found to be located in a small gene cluster within 100
kb with the mouse Bacat (Fig. 1A) . These newly identified genes were named Acnat1
and Acnat2 and are both encoded by 3 exons, which is similar to the exon pattern in
Bacat and the Type-I Acot genes (20) . In this study, we have characterized the ACNAT1 in detail. Alignment of the amino acid sequence of ACNAT1 to mouse BACAT shows that this protein is approximately 52% identical to BACAT (Fig. 1B ).
The ACNAT1 also shows approximately 45% sequence identity to ACOT enzymes, which act as thioesterases, but is more closely related to BACAT, a conjugating enzyme. Characterization of the active site amino acids of the Type-I ACOTs and BACAT revealed a catalytic triad consisting of a nucleophilic serine residue in the ACOT enzymes (24), or a nucleophilic cysteine residue in BACAT (5, 25), a histidine and an aspartic acid. The amino acid residues of the catalytic triad are all conserved in ACNAT1, with the ACNAT1 active site containing a serine in a SerXaaSerXaaGly motif (Fig. 1B) .
ACNAT1 is localized in Peroxisomes-ACNAT1 contains the tripeptide serine-lysineleucine (-SKL) at its carboxyterminal, which is the consensus sequence of the peroxisomal type 1 targeting signal that targets proteins to peroxisomes (26) . To test if ACNAT1 is indeed peroxisomal, we expressed the protein in-frame with GFP, leaving the carboxyterminal -SKL accessible. ACNAT1 was expressed in control fibroblasts and fibroblasts from a Zellweger patient, which are unable to import peroxisomal matrix proteins. Immunofluorescence microscopy revealed a punctate pattern of expression in control fibroblasts, indicative of a peroxisomal localization ( Fig. 2A) . When the same construct was transfected into Zellweger fibroblasts, this resulted in a diffuse GFP pattern, showing that the protein was not imported into peroxisomes but remained in cytosol (Fig. 2B) . FAAH has been shown to hydrolyze NATs back to the free fatty acid and taurine, with the activity varying depending on the chain length of the NAT, with C18:1 NAT being a better substrate for FAAH than C24 NAT (29, 30) . This hydrolysis by FAAH could account for the low levels of NATs in-vivo, which are in the pmol/g range in brain, CNS, testes and liver, however these rise to nmol/g tissue in the CNS and spinal cord in the FAAH knockout mouse model (29) . Acnat1 is mainly expressed in liver and kidney and there was only very weak mRNA expression in mouse whole brain, indicating that it is unlikely that ACNAT1 produces NATs in-situ in the CNS.
ACNAT1 is an acyltransferase that can conjugate fatty acids to taurine -
Alternatively these NATs may be synthesized peripherally in the liver and kidney and could then be transported to the CNS. It has been hypothesized that a similar situation could exist in relation to glycine conjugates of fatty acids (N-acylglycines) and that hepatically derived NATs may be amidated by the bifunctional peptidylglycine α-amidating enzyme (α-AE) and then cross the blood-brain barrier (31) . Recently however, glycine conjugates of arachidonic acid have been detected in bovine and rat brain and are synthesized in-situ in rat brain as bioactive molecules that inhibit pain The fact that ACNAT1 is a peroxisomal enzyme raises the question of the role of ACNAT1 in this organelle. Peroxisomes are associated with the metabolism of several xenobiotic acyl compounds (13), together with the β-oxidation of very longchain fatty acids, bile acid intermediates, and α-oxidation and β-oxidation of branched chain fatty acids (33) . Prostaglandins are also chain shortened in peroxisomes, followed by excretion in urine (34) . Interestingly, novel taurine conjugated metabolites of prostaglandin E 2 were identified in rat hepatocytes following β-oxidation (35), suggesting that partial β-oxidation of prostaglandins in peroxisomes followed by taurine conjugation of the metabolites is a means of excreting these lipids. Our finding here of a peroxisomal fatty acid taurine conjugating enzyme suggests that the entire process of partial β-oxidation followed by taurine conjugation occurs in peroxisomes. Similarly, bile acid intermediates are (side) chain shortened by β-oxidation followed by taurine (and glycine) conjugation in peroxisomes, which is the final step in de-novo bile acid synthesis and following conjugation, these bile acids are excreted into bile. Again, this conjugation results in more polar compounds for excretion and increases the detergent properties of bile acids in the intestine. Thus peroxisomal taurine conjugation of prostaglandins and bile acids results in products that are more easily excreted. In a similar way, the formation of long chain NATs by ACNAT1 in peroxisomes would also result in the production of more polar lipids for excretion. Although levels of NATs are low under normal conditions, it may be that ACNAT1 is more active under pathophysiological conditions where high levels of potentially toxic fatty acids prevail and the conjugation of these fatty acids to taurine would provide an excretory pathway in bile or urine (Fig. 6 ). In peroxisomes, carnitine is involved in the transfer of β-oxidation products to the mitochondria for further oxidation and several peroxisomal carnitine acyltransferase enzymes have been identified (36, 37) , These carnitine acyltransferases have a similar catalytic mechanism to ACNAT1, by catalyzing the transfer of the acyl moiety of acyl-CoAs to carnitine, the acceptor. However, these acyltransferases are only active on medium-and short-chain fatty acids, while ACNAT1 is active on long-chain and very long-chain fatty acids. Thus the formation of NATs may also allow fatty acids to be transferred within the cell, in a similar manner to acylcarnitines. Under pathophysiological conditions when long chain acylCoAs accumulate in mitochondria, they are converted to acylcarnitines that leave the mitochondria and can readily be assayed in blood (38) . Interestingly, acylcarnitines are also secreted in bile and it was shown that these bile acylcarnitines were elevated in mice deficient in mitochondrial long-chain and very long-chain acyl-CoA dehydrogenases (39) . Thus, a fatty acid taurine conjugating system in peroxisomes may function in analogy to the mitochondrial carnitine acyltransferase system in mitochondria to eliminate fatty acids under conditions of fatty acid overload.
From an evolutionary point of view, ACNAT1 is related to both the BACAT enzyme and to a family of enzymes called Type-I acyl-CoA thioesterases (ACOTs) (for review see (18) identical to ACNAT1, which we named Acnat2. Although we have not as yet been able to identify the substrate for ACNAT2, we propose that also Acnat2 encodes an acyltransferase, given the very high percentage sequence identity to Acnat1. Thus
Bacat, Acnat1 and Acnat2 comprise a novel gene cluster involved in conjugation processes for elimination of metabolites. As ACNAT1 and the ACOTs utilize the same substrate (acyl-CoAs) it is easy to envisage competitive or complementary functions for the two enzyme systems ( 
